Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1119 Results

Title
Intervention Indication Therapeutic Area Year Actions
Belantamab mafodotin for relapsed / refractory multiple myeloma – Fourth line Belantamab mafodotin (GSK2857916; anti-BCMA-ADC) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2019 View  |  Download
BCX7353 for prevention of acute attacks of angioedema in hereditary angioedema BCX7353 (Berotralstat; ORLADEYO) Hereditary angioedema (HAE) Genetic Disorders , Immunology 2019 View  |  Download
bb2121 for Relapsed and Refractory Multiple Myeloma Idecabtagene vicleucel (Ide-cel; bb2121) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2018 View  |  Download
Basal Insulin-Fc for type 2 diabetes mellitus Basal Insulin-Fc Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Basal Insulin-Fc for treating type 1 diabetes Basal Insulin-Fc Type 1 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Baricitinib for treatment of severe alopecia areata in adults Baricitinib (LY3009104; Olumiant) Alopecia areata Dermatology , Immunology 2021 View  |  Download
Baricitinib for treating juvenile idiopathic arthritis in paediatric patients Baricitinib (LY3009104; Olumiant) Juvenile psoriatic arthritis Rheumatology 2022 View  |  Download
Baricitinib for treating atopic dermatitis in children and adolescents Baricitinib (LY3009104; Olumiant) Atopic dermatitis Dermatology 2022 View  |  Download
Baricitinib for systemic lupus erythematosus Baricitinib (LY3009104; Olumiant) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Baricitinib for moderate to severe atopic dermatitis Baricitinib (LY3009104; Olumiant) , Corticosteroids Atopic dermatitis Dermatology 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications